German UV technology specialist Hoenle AG has seen its share price rally in recent months, yet analysts suggest it may still trade below its intrinsic value. We examine whether this small-cap stock presents a buying opportunity or carries hidden risks.
The Canadian government is moving to recover millions in past incentives following General Motors' second round of layoffs at its Oshawa plant in six months, casting a shadow over the automaker's employment pledges and future capital allocation plans.
Asian equities staged a strong recovery on Tuesday, with South Korea's Kospi and Japan's Nikkei leading gains as investors returned to tech stocks. The rebound follows recent volatility, with markets now focused on corporate earnings and geopolitical risks.
The U.S. decision to slash tariffs on Indian goods has been met with cautious optimism by Indian industry, though analysts urge restraint until the full scope of the agreement is clarified.
Amidst record market levels, analysts highlight a select group of companies—from AI leaders to emerging fintech—with strong fundamentals and room for significant expansion.
In a significant diplomatic and economic breakthrough, the U.S. agrees to slash tariffs on Indian goods after Prime Minister Modi commits to halt purchases of Russian crude, easing bilateral tensions and reshaping trade dynamics.
Blue Bird Corporation (BLBD) is poised to release its latest quarterly results after Wednesday's market close. Investors will be watching to see if the manufacturer can maintain its pattern of outperforming Wall Street's forecasts amidst a mixed landscape for heavy equipment peers.
The global electronics manufacturer is poised to release its quarterly results Wednesday, with investors watching for signs of stabilization after a period of revenue contraction.
Eli Lilly's $3.5 billion investment in a new Pennsylvania facility for injectable weight-loss drugs, including retatrutide, spotlights its aggressive expansion in the obesity market. This strategic move, coupled with strong analyst sentiment and upcoming earnings, intensifies focus on the company's growth trajectory and premium valuation.
As Regal Rexnord prepares to release its fourth-quarter results, investors are watching to see if the industrial automation leader can sustain its recent stock momentum and deliver on growth forecasts in a mixed earnings season for machinery peers.
The pharmaceutical giant is set to release quarterly results before the bell Wednesday, with Wall Street anticipating another period of blockbuster revenue growth driven by its GLP-1 drugs.
All eyes are on Qualcomm as it prepares to release its quarterly earnings. With a strong track record of surpassing estimates, analysts are watching for signs of resilience in the smartphone and IoT markets.
Standex International (NYSE:SXI) reports robust organic growth driven by its Electronics division, alongside strategic capacity expansion and a strengthened balance sheet, culminating in a raised dividend for shareholders.
As Fortive prepares to release its fourth-quarter results, investors are weighing slowing revenue growth projections against a backdrop of robust peer performance and cautious analyst sentiment. The industrial technology firm's ability to meet or exceed forecasts could signal its resilience in a fluctuating market.
All eyes are on Stanley Black & Decker (SWK) as it prepares to release its quarterly earnings. Investors are looking for signs of a sustained turnaround amid a mixed industrial machinery landscape.
As Kennametal (KMT) prepares to release its quarterly results, investors are weighing strong recent performance against a history of revenue misses. The report comes amid mixed signals from the industrial machinery sector.
CDW Corporation is set to report its fourth-quarter earnings before the market opens on Wednesday. Analysts project modest revenue growth, but the company's recent performance and broader sector trends suggest a cautious outlook.
The Timken Company (NYSE: TKR) is scheduled to release its fourth-quarter financial results before the market opens on Wednesday. Investors will be watching to see if the bearings and power transmission specialist can continue its track record of surpassing Wall Street's forecasts amidst a mixed landscape for industrial machinery firms.
Beyond the headlines of cash burn and production woes, Rivian Automotive is executing a strategic pivot. With falling costs, the imminent launch of its mass-market R2, and a growing software revenue stream, the company is laying the groundwork to transform from a pure EV manufacturer into a vertically integrated autonomy platform.
French biotech Abivax sees renewed investor interest following strong Phase 3 data for its oral therapy obefazimod in hard-to-treat ulcerative colitis, with analysts pointing to a clear path to regulatory approval and significant market potential.
